Literature DB >> 12176274

Caffeine microparticles for nasal administration obtained by spray drying.

C Sacchetti1, M Artusi, P Santi, P Colombo.   

Abstract

This study investigated the possibility to use spray drying technique to prepare powders formulations containing caffeine intended for nasal delivery. Spray dried powders containing caffeine and excipients, as filler and shaper agents, were prepared. Powders were investigated for particle size, morphology and delivery properties from Monopowder P nasal insufflator, assessing the influence of each excipient on microparticles characteristics. The results showed that the excipients strongly affected microparticle properties. Size, shape and agglomeration tendency are relevant characteristics of spray dried nasal powder.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176274     DOI: 10.1016/s0378-5173(02)00177-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate.

Authors:  Giovanna Rassu; Elena Soddu; Massimo Cossu; Antonio Brundu; Guido Cerri; Nicola Marchetti; Luca Ferraro; Raymond F Regan; Paolo Giunchedi; Elisabetta Gavini; Alessandro Dalpiaz
Journal:  J Control Release       Date:  2015-01-22       Impact factor: 9.776

2.  Spray-dried mucoadhesive microspheres: preparation and transport through nasal cell monolayer.

Authors:  Saraporn Harikarnpakdee; Vimolmas Lipipun; Narueporn Sutanthavibul; Garnpimol C Ritthidej
Journal:  AAPS PharmSciTech       Date:  2006-02-10       Impact factor: 3.246

3.  Electro-physiological changes in the brain induced by caffeine or glucose nasal spray.

Authors:  K De Pauw; B Roelands; J Van Cutsem; U Marusic; T Torbeyns; R Meeusen
Journal:  Psychopharmacology (Berl)       Date:  2016-09-23       Impact factor: 4.530

4.  In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates.

Authors:  Alessandro Giuliani; Anna Giulia Balducci; Elisa Zironi; Gaia Colombo; Fabrizio Bortolotti; Luca Lorenzini; Viola Galligioni; Giampiero Pagliuca; Alessandra Scagliarini; Laura Calzà; Fabio Sonvico
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

5.  The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability.

Authors:  Giovanna Rassu; Luca Ferraro; Barbara Pavan; Paolo Giunchedi; Elisabetta Gavini; Alessandro Dalpiaz
Journal:  Pharmaceutics       Date:  2018-10-26       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.